Michael Bubser Selected Research

Michael Bubser Research Topics

Disease

13	Schizophrenia (Dementia Praecox) 11/2020 - 02/2005
8	Parkinson Disease (Parkinson's Disease) 01/2017 - 07/2009
5	Alzheimer Disease (Alzheimer's Disease) 12/2020 - 10/2008
5	Catalepsy 01/2016 - 10/2008
3	Opioid-Related Disorders (Opiate Addiction) 01/2023 - 01/2019
2	Pain (Aches) 05/2019 - 01/2019
2	Neurobehavioral Manifestations 01/2018 - 01/2012
2	Dyskinesias (Dyskinesia) 01/2016 - 08/2015
2	Parkinsonian Disorders (Parkinsonism) 03/2012 - 07/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2020
1	Substance-Related Disorders (Drug Abuse) 03/2016
1	Cocaine-Related Disorders (Cocaine Addiction) 03/2016
1	Fragile X Syndrome (Martin Bell Syndrome) 01/2016
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 03/2015
1	Psychotic Disorders (Schizoaffective Disorder) 06/2014
1	Nerve Degeneration 03/2012
1	Nervous System Diseases (Neurological Disorders) 01/2012
1	Angelman Syndrome (Syndrome, Angelman) 09/2010
1	MPTP Poisoning 07/2009
1	Weight Loss (Weight Reduction) 08/2002
1	Weight Gain 08/2002
1	Body Weight (Weight, Body) 08/2002

Drug/Important Bio-Agent (IBA)

9	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2023 - 10/2008
4	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2016 - 02/2012
4	Haloperidol (Haldol)FDA LinkGeneric 01/2016 - 02/2012
4	Antipsychotic Agents (Antipsychotics)IBA 01/2012 - 08/2002
3	Opioid Analgesics (Opioids)IBA 01/2023 - 01/2019
3	Glutamate Receptors (Glutamate Receptor)IBA 12/2016 - 05/2015
3	N-Methylaspartate (NMDA)IBA 12/2016 - 05/2015
3	Levodopa (L Dopa)FDA LinkGeneric 01/2016 - 02/2012
3	Dopamine (Intropin)FDA LinkGeneric 03/2012 - 02/2005
2	Cholinergic Agents (Cholinergics)IBA 12/2020 - 01/2012
2	Analgesics (Analgesic Drugs)IBA 05/2019 - 01/2019
2	VU0466551IBA 05/2019 - 01/2019
2	Morphine (MS Contin)FDA LinkGeneric 05/2019 - 01/2019
2	Dizocilpine Maleate (Dizocilpine)IBA 01/2018 - 03/2016
2	Clozapine (Clozaril)FDA LinkGeneric 03/2016 - 08/2002
2	metabotropic glutamate receptor 4IBA 01/2016 - 08/2015
2	N-(3-chlorophenyl)picolinamideIBA 08/2015 - 02/2012
2	Serotonin (5 Hydroxytryptamine)IBA 03/2015 - 07/2009
2	Oxidopamine (6 Hydroxydopamine)IBA 03/2012 - 02/2012
2	OrexinsIBA 11/2007 - 08/2002
1	VU6019650IBA 01/2022
1	Opioid Receptors (Opioid Receptor)IBA 01/2019
1	VU0467485IBA 02/2017
1	VU0476406IBA 01/2017
1	5- amino- 3,4- dimethyl- N- (4- ((trifluoromethyl)sulfonyl)benzyl)thieno(2,3- c)pyridazine- 6- carboxamideIBA 03/2016
1	Hypnotics and Sedatives (Sedatives)IBA 03/2016
1	Metabotropic Glutamate 5 ReceptorIBA 03/2016
1	Therapeutic UsesIBA 01/2016
1	gamma-Aminobutyric Acid (GABA)IBA 08/2015
1	Dihydroxyphenylalanine (Dopa)IBA 08/2015
1	LSP1 2111IBA 08/2015
1	Glutamic Acid (Glutamate)FDA Link 08/2015
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 03/2015
1	Neuropeptide YIBA 03/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2015
1	SaltsIBA 03/2013
1	metabotropic glutamate receptor 8IBA 03/2013
1	Reserpine (Serpasil)FDA Link 03/2013
1	2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA 02/2012
1	Adenosine (Adenocard)FDA LinkGeneric 02/2012
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2012
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2012
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2012
1	Muscarinic AgonistsIBA 01/2012
1	Cholinergic ReceptorsIBA 01/2012
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 09/2010
1	Proteins (Proteins, Gene)FDA Link 09/2010
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2009
1	NeurotensinIBA 02/2005
1	Peptides (Polypeptides)IBA 08/2002
1	Amphetamine (Amfetamine)FDA LinkGeneric 08/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 03/2016
1	Denervation 07/2009